Literature DB >> 8276044

The effect of prostaglandin E1 during cardiopulmonary bypass on renal function after cardiac surgery.

K Abe1, Y Fujino, T Sakakibara.   

Abstract

We have evaluated the effect of prostaglandin E1 (PGE1) on renal function after cardiac surgery with cardiopulmonary bypass in 20 patients, ten of whom received 0.02 microgram.kg-1.min-1 of PGE1 by infusion into the oxygenator during bypass; ten patients served as controls. Serum beta 2-microglobulin fell significantly and urine beta 2-microglobulin increased significantly after surgery in both groups. Urine N-acetyl-beta-D-glucosaminidase was high after surgery in both groups, but it was significantly lower in the PGE1 group. Free water clearance fell significantly on the 1st, 3rd, and 5th postoperative days compared with preoperative values in the control but not in the PGE1 group. These results suggest that PGE1 may prevent renal dysfunction after cardiopulmonary bypass.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8276044     DOI: 10.1007/bf00315386

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  23 in total

1.  Urinary osmolal changes in renal dysfunction following open-heart operations.

Authors:  T Heimann; S Brau; H Sakurai; E C Peirce
Journal:  Ann Thorac Surg       Date:  1976-07       Impact factor: 4.330

2.  Femoral-artery infusion of prostaglandin E 1 in severe peripheral vascular disease.

Authors:  L A Carlson; I Eriksson
Journal:  Lancet       Date:  1973-01-20       Impact factor: 79.321

3.  Isolation and properties of a low molecular weight beta-2-globulin occurring in human biological fluids.

Authors:  I Berggård; A G Bearn
Journal:  J Biol Chem       Date:  1968-08-10       Impact factor: 5.157

4.  Effects of furosemide and acetylcholine in norepinephrine-induced acute renal failure.

Authors:  A De Torrente; P D Miller; R E Cronin; P E Paulsin; A L Erickson; R W Schrier
Journal:  Am J Physiol       Date:  1978-08

5.  Studies on renal tubular protein reabsorption: partial and near complete inhibition by certain amino acids.

Authors:  C E Mogensen
Journal:  Scand J Clin Lab Invest       Date:  1977-10       Impact factor: 1.713

6.  Effects of hypothermia, hemodilution, and pump oxygenation on organ water content, blood flow and oxygen delivery, and renal function.

Authors:  J R Utley; C Wachtel; R B Cain; E A Spaw; J C Collins; D B Stephens
Journal:  Ann Thorac Surg       Date:  1981-02       Impact factor: 4.330

7.  Acquired renal insufficiency in critically ill patients.

Authors:  P I Menashe; S A Ross; J E Gottlieb
Journal:  Crit Care Med       Date:  1988-11       Impact factor: 7.598

8.  Acute renal failure following cardiac operations.

Authors:  P Gailiunas; R Chawla; J M Lazarus; L Cohn; J Sanders; J P Merrill
Journal:  J Thorac Cardiovasc Surg       Date:  1980-02       Impact factor: 5.209

9.  Prostaglandin E1 as a hypotensive drug during general anaesthesia.

Authors:  F Goto; E Otani; S Kato; T Fujita
Journal:  Anaesthesia       Date:  1982-05       Impact factor: 6.955

10.  Hemodynamic effects of prostaglandin E1 during cardiopulmonary bypass in infants and children.

Authors:  M Kawamura; O Minamikawa; H Yokochi; S Maki; T Yasuda; Y Mizukawa
Journal:  Jpn J Surg       Date:  1982
View more
  3 in total

Review 1.  Prevention and treatment of acute kidney injury in patients undergoing cardiac surgery: a systematic review.

Authors:  Meyeon Park; Steven G Coca; Sagar U Nigwekar; Amit X Garg; Susan Garwood; Chirag R Parikh
Journal:  Am J Nephrol       Date:  2010-04-06       Impact factor: 3.754

2.  Pharmacological therapies for the prevention of acute kidney injury following cardiac surgery: a systematic review.

Authors:  Nishith N Patel; Chris A Rogers; Gianni D Angelini; Gavin J Murphy
Journal:  Heart Fail Rev       Date:  2011-11       Impact factor: 4.214

Review 3.  Interventions for protecting renal function in the perioperative period.

Authors:  Mathew Zacharias; Mohan Mugawar; G Peter Herbison; Robert J Walker; Karen Hovhannisyan; Pal Sivalingam; Niamh P Conlon
Journal:  Cochrane Database Syst Rev       Date:  2013-09-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.